Description
The DC Recruiter is a broad-spectrum immune enhancer that uses a self-assembling peptide nanofiber to recruit and activate dendritic cells, helping the body respond faster to infections. This technology has the potential to provide broad-spectrum immune support across many different infectious threats and can be used in various settings, including outbreak response, emergency preparedness, and consumer health and wellness. The key advantages of this technology include its ability to work in a broad, pathogen-agnostic way, target dendritic cells, and be easier to use due to its needle-free, spray-friendly concept.
Some of the key points about this opportunity include:
• The DC Recruiter addresses a persistent gap in infection management by providing a rapid, broadly effective way to stimulate immune defense.
• It has the potential to be useful in outbreak, emergency, or high-risk settings.
• The technology is designed to help trigger an early immune response regardless of the infecting agent.
• It has a wide range of market applications, including infectious disease prevention, outbreak response, and consumer health and wellness.
• The technology is currently at a development status of TRL 3, and a US patent is pending.
Attached files
Contact
Caleb Ledgerwood